Strategic Collaboration Partner with healthcare and harm-reduction initiatives leveraging WHPM's rapid membrane tests to expand distribution in clinics, hospitals, and community health programs, similar to their existing DanceSafe collaboration.

Low-Cost Testing Position WHPM’s rapid one-step tests as affordable diagnostic solutions for price-sensitive markets and emerging geographies, highlighting potential to win contracts in public health, occupational health, and point-of-care settings.

Regulatory Advantage Emphasize FDA GMP-certified in vitro diagnostic capabilities to secure opportunities with government agencies, private labs, and larger medical device distributors seeking compliant rapid test products.

Medium-Size Enterprise Target mid-market healthcare distributors and regional manufacturers seeking scalable, compliant, small-to-mid-volume production partners, aligning with WHPM’s current 11-50 employee profile and mid-range revenue.

Innovation Pipeline Highlight WHPM’s focus on one-step rapid membrane tests to explore adjacent strip-based diagnostics, enabling cross-sell into broader rapid assay portfolios and custom testing solutions for diverse customer segments.